As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Iveda Solutions, Inc. The largest reported stake is Lind Global Fund III LP's, at 9.99%. 5 filings are on record since February 13, 2026 (Schedule 13G/A, August 14, 2026).
Sell to companies like Iveda Solutions, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Lind Global Fund III LP · Sole voting: 1,286,794 · Shared voting: 0 · Sole dispositive: 1,286,794 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-14
- · Reporting person: Iroquois Capital Management, LLC · Sole voting: 0 · Shared voting: 585,068 · Sole dispositive: 0 · Shared dispositive: 585,068 · SCHEDULE 13G/A, 2026-05-15
- · Holder: Lind Global Fund III LP · Percent: 9.99% · SCHEDULE 13G
- · Holder: Richard Abbe · Percent: 6.4% · SCHEDULE 13G
- · Holder: Mitchell P. Kopin · Percent: 4.99% · SCHEDULE 13G
Iveda Solutions, Inc. has 5 Schedule 13D or 13G filings on record since 2026-02-13. 1 holder's latest filing reports 5% or more of common stock, par value $0.00001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Lind Global Fund III LP | 9.99% | 1,286,794 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| Iroquois Capital Management, LLC | 4.99% | 585,068 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| 4.99% | 592,195 | SCHEDULE 13G, 2026-02-13 | 2026-02-09 |
Holding shares or following this stake? See who's behind Iveda Solutions, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Iveda Solutions, Inc. and the records around it.
Iveda Solutions, Inc. elsewhere on the record
Companies that share a holder
- Lind Global Fund III LP also filed stake reports on 11 other companies: Dare Bioscience, Inc. (Aug 2026), DEFSEC Technologies Inc. (Aug 2026), Enveric Biosciences, Inc. (Aug 2026)
- Iroquois Capital Management, LLC also filed stake reports on 13 other companies: 22nd Century Group (Aug 2026), XWELL, Inc. (Aug 2026), Clearmind Medicine Inc. (Aug 2026)
- Mitchell P. Kopin also filed stake reports on 55 other companies: SCWorx Corp. (Sep 2026), NFT Limited (Aug 2026), Silexion Therapeutics Corp (Aug 2026)
Watch Iveda Solutions, Inc.
Get an email when Iveda Solutions, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Iveda Solutions, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Iveda Solutions, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Iveda Solutions, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Lind Global Fund III LP | 1,286,794 | 0 | 1,286,794 | 0 | SCHEDULE 13G/A, 2026-08-14 |
| Lind Global Partners III LLC | 1,286,794 | 0 | 1,286,794 | 0 | SCHEDULE 13G/A, 2026-08-14 |
| Jeff Easton | 1,286,794 | 0 | 1,286,794 | 0 | SCHEDULE 13G/A, 2026-08-14 |
| Iroquois Capital Management, LLC | 0 | 585,068 | 0 | 585,068 | SCHEDULE 13G/A, 2026-05-15 |
| Richard Abbe | 428,572 | 585,068 | 428,572 | 585,068 | SCHEDULE 13G/A, 2026-05-15 |
| Kimberly Page | 0 | 585,068 | 0 | 585,068 | SCHEDULE 13G/A, 2026-05-15 |
The latest filing identifies Iveda Solutions, Inc. by CUSIP 46583A303 and gives its principal executive office as 1744 S Val Vista, Suite 213, Mesa, AZ 85204 (SCHEDULE 13G/A, 2026-08-14).
What the percentages are based on
Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the securities of the Issuer beneficially owned by such Reporting Person as of the date of the event which requires filing of this statement and is incorporated herein by reference.Iroquois Capital Management, LLC, SCHEDULE 13G/A, 2026-05-15
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-02-13 | Richard Abbe | 6.4% | SCHEDULE 13G |
| 2026-02-13 | Mitchell P. Kopin | 4.99% | SCHEDULE 13G |
| 2026-02-19 | Lind Global Fund III LP | 9.99% | SCHEDULE 13G |
| 2026-05-15 | Iroquois Capital Management, LLC | 4.99% | SCHEDULE 13G/A |
| 2026-08-14 | Lind Global Fund III LP | 9.99% | SCHEDULE 13G/A |
Questions about who owns Iveda Solutions, Inc.
Who owns Iveda Solutions, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Iveda Solutions, Inc.: Lind Global Fund III LP (9.99%, Schedule 13G/A, filed 2026-08-14).
When did Lind Global Fund III LP buy into Iveda Solutions, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Lind Global Fund III LP on this page is the Schedule 13G, filed 2026-02-19, reporting 9.99%; its latest, Schedule 13G/A filed 2026-08-14, reports 9.99%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Iveda Solutions, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.